Risk of SARS-CoV-2 infection during the omicron surge in patients on dialysis

In a recent study published in Journal of the American Society of Nephrology, a third COVID-19 mRNA vaccine dose in adults with kidney failure who were on dialysis enhanced patients' protection against SARS-CoV-2 infection during the omicron-dominant period. A patient's response to vaccination or prior infection—as measured by circulating anti-SARS-CoV-2 antibody levels—was also an important predictor for subsequent risk of infection.